This will require continued investment in the foundational science to elucidate remaining unknowns regarding how pain works in the body and brain, which in turn can direct us to even more targeted strategies to address the physiology behind specific pain types.
Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Virtual reality has evolved from being a technological novelty to a legitimate clinical tool in areas like chronic pain management and neurological rehab, leading experts to think through how best to integrate VR into healthcare.
Recently, the San Francisco-based health plan reported positive results that showed a 56 percent reduction in overall opioid use among members with chronic, non-cancer pain from 2014 levels.
The $50,000 challenge was sponsered by the Robert Wood Johnson Foundation to help find a tech-enabled approach to addressing substance abuse of opioids.
Despite being just four years old, Centrexion, which just raised $67 million, is building a significant pipeline of non-opioid, non-steroidal pain medications.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
As the opioid crisis continues to be top of mind in America, Yale New Haven Health, Yale School of Medicine, Appriss Health and the State of Connecticut have teamed up to better tackle abuse.
Electronic prescribing of controlled substances (EPCS) is finally gaining momentum, but there are common misconceptions.
The move is prompting worry from some physicians who say it could have the unintended consequence of keeping appropriate medical treatment from people with chronic pain.
Investigative journalism lives in some unlikely places, such as on HBO's "Last Week Tonight with John Oliver." This week, host John Oliver — you know, a comedian by trade — took a deep look at the opioid epidemic in America.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
In one of the first looks at privately insured patients with opioid problems, researchers paint a grim picture: Medical services for people with opioid dependence diagnoses skyrocketed more than 3,000 percent between 2007 and 2014.
The Kaiser survey also examined Americans’ views on issues involving access to mental health services.
Modifications from generic drugmakers could, say, make these drugs harder to crush and snort, smoke or dissolve to inject intravenously, as seen in a new FDA draft guidance.
What was once just a very useful medication in hospitals for those in pain could now be the source of the next real life 'Breaking Bad' scenario.